Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
GA.7.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GA.7.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.403ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.403ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.403ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.403NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
A.27ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
A.27ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
A.27ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
A.27NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.1.30ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.1.30ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.30ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.30NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.9ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.9ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.9NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GW.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GW.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GW.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GW.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.40ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.40ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.40ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.40NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FY.7ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FY.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FY.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FY.7NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.2.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.2.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.2.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.2.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.367ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.367ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.367ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.367NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GK.1.9ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GK.1.9ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GK.1.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GK.1.9NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BN.1.3.13ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BN.1.3.13ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BN.1.3.13ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.1.3.13NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.385ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.385ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.385ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.385NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used